Skip to content

Clinical trials

Gastrointestinal Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Country / region: Japan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20161
20172
20202
20211
20224
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Kissei Pharmaceutical Co., Ltd.3
Pfizer2
Amgen1
Astellas Pharma Inc1
AstraZeneca1
Eli Lilly and Company1
IDRX, Inc., a wholly owned subsidiary of GSK, LLC1
National Cancer Center Hospital East1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases17
Digestive System Diseases8
Gastrointestinal Neoplasms7
Intestinal Diseases6
Colonic Diseases5
Colorectal Neoplasms4
Digestive System Neoplasms4
Gastroenteritis4
Intestinal Neoplasms4
Neoplasms4

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.